Bringing Optimised COVID-19 Vaccine Schedules To ImmunoCompromised Populations (BOOST-IC): an Adaptive Randomised Controlled Clinical Trial
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- James H McMahon, MBBS PhD
Alfred Hospital, Melbourne, Australia
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- St Vincents Hospital
Darlinghurst, New South Wales, Australia
- Prince of Wales Hospital
Randwick, New South Wales, Australia
- Westmead Hospital
Westmead, New South Wales, Australia
- Royal Brisbane and Womens Hospital
Herston, Queensland, Australia
- Princess Alexandra Hospital
Woolloongabba, Queensland, Australia
- Royal Adelaide Hospital
Adelaide, South Australia, Australia
- Monash Medical Centre
Clayton, Victoria, Australia
- St Vincents Hospital
Fitzroy, Victoria, Australia
- University Geelong Hospital
Geelong, Victoria, Australia
- Austin Hospital
Heidelberg, Victoria, Australia
- Alfred Health
Melbourne, Victoria, Australia
- Peter Maccallum Cancer Centre
Melbourne, Victoria, Australia
- Royal Melbourne Hospital
Melbourne, Victoria, Australia
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Dec 2022
- Primary completion
- 30 Jun 2026
- Completion
- 31 Dec 2026
- Last update posted
- 3 Oct 2025
- Registered enrollment
- 960
- Registry id
- NCT05556720
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.